Nikhilesh Chand
About Nikhilesh Chand
Nikhilesh Chand serves as the Chief Strategy Officer in Residence at BridgeBio, having previously held various roles in consulting and finance, including positions at The Boston Consulting Group and Viking Global Investors. He holds a PhD in Biochemistry from Harvard University and has extensive experience in market analysis and strategy within the biotechnology sector.
Current Role at BridgeBio
Nikhilesh Chand serves as the Chief Strategy Officer in Residence at BridgeBio since 2023. In this role, he focuses on strategic initiatives and the overall direction of the company. His position allows him to leverage his extensive experience in the biotech sector to guide the organization in achieving its goals.
Previous Experience at BridgeBio
Before his current role, Nikhilesh Chand worked at BridgeBio as Senior Vice President of M&A from 2020 to 2023. During this time, he was responsible for overseeing mergers and acquisitions, contributing to the company's growth and strategic positioning in the biotechnology industry.
Professional Background
Nikhilesh Chand has a diverse professional background. He worked at The Boston Consulting Group as a Consultant from 2013 to 2014, followed by a position at Genentech from 2014 to 2016, where he focused on market analysis and strategy. He then served as an Analyst at Viking Global Investors from 2016 to 2019.
Education and Academic Involvement
Nikhilesh Chand has a strong academic background in biochemistry. He completed his PhD at Harvard University from 2007 to 2012 and also earned an MA (Cantab.) in Biochemistry from the University of Cambridge from 2005 to 2007. He studied Chemistry at St. Stephen's College, Delhi, achieving a BS from 2002 to 2005. Additionally, he served as a Teaching Fellow and Graduate Research Assistant at Harvard University.